The following abstracts represent the presentations given at IWWM-9 (Amsterdam-2016), Session 11: Novel Therapeutic approaches for WM:
Session Chair: M.J. Kersten (Netherlands)
What should we expect from BCL-2 inhibitors in the management of WM? M. Davids (USA)
Do checkpoint inhibitors offer a novel therapeutic strategy in WM? S. Ansell (USA)
Could monoclonal antibodies targeting plasma cells benefit WM patients? K. Anderson (USA)
Is CAR T-cell immunotherapy appropriate for WM patients? D. Maloney (USA)